TheraRadar
Clinical-Stage Companies / Yuhan Corporation

Yuhan Corporation

Pre-Approval PRO BETA
96
Total Trials
11
Phase 3
20
Phase 2
8
Recruiting
520
Score

Pipeline by Phase

Phase 3
11
Phase 2
20
Phase 1
55

Therapeutic Focus

Hypertension Healthy Hyperlipidemia Healthy Volunteer Healthy Volunteers

Clinical Trials (96)

NCT06625957 Phase 3 RECRUITING

Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

Started: 12/4/2024

NCT07111468 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis

Started: 8/19/2025

NCT06625931 Phase 3 COMPLETED

Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition

Started: 11/14/2024

NCT04248829 Phase 3 ACTIVE NOT RECRUITING

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

Started: 2/13/2020

NCT02620163 Phase 3 COMPLETED

Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment

Started: 12/1/2015

NCT03067688 Phase 3 COMPLETED

Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

Started: 4/11/2017

NCT02985216 Phase 3 COMPLETED

Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain

Started: 2/7/2017

NCT02586129 Phase 3 COMPLETED

Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

Started: 11/4/2015

NCT03103256 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of YHP1701

Started: 5/17/2017

NCT01400828 Phase 3 COMPLETED

Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis

Started: 6/1/2011

NCT01914432 Phase 3 COMPLETED

Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

Started: 11/1/2013

NCT07415551 Phase 2 RECRUITING

Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines

Started: 3/26/2026

NCT02567578 Phase 2 TERMINATED

A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

Started: 10/1/2015

NCT02585596 Phase 2 COMPLETED

A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.

Started: 12/16/2015

NCT02759198 Phase 2 COMPLETED

A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

Started: 5/2/2016

NCT02320019 Phase 2 COMPLETED

Clinical Trial of YH14618 in Patients With Degenerative Disc Disease

Started: 3/1/2015

NCT01507038 Phase 2 COMPLETED

Safety and Efficacy of YH14617 in Diabetes Mellitus

Started: 12/1/2011

NCT01423370 Phase 2 COMPLETED

Safety and Efficacy of YHD1023 in Erectile Dysfunction

Started: 11/1/2011

NCT01499225 Phase 2 COMPLETED

A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease

Started: 12/1/2011

NCT01538849 Phase 2 COMPLETED

Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis

Started: 12/1/2012

NCT01750437 Phase 2 COMPLETED

Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

Started: 1/1/2013

NCT01424124 Phase 2 COMPLETED

Safety and Efficacy of YHD001 in Asthma

Started: 11/1/2011

NCT01420445 Phase 2 COMPLETED

Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis

Started: 9/1/2011

NCT05523947 Phase 1 RECRUITING

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

Started: 8/26/2022

NCT06517914 Phase 1 RECRUITING

A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants

Started: 7/29/2024

NCT06616766 Phase 1 RECRUITING

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

Started: 10/2/2024

NCT06975410 Phase 1 RECRUITING

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Started: 6/12/2025

NCT07470125 Phase 1 NOT YET RECRUITING

Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers

Started: 6/23/2026

NCT07265167 Phase 1 COMPLETED

Bioequivalence Study Between YHP2406 and YHR2501 in Healthy Subjects

Started: 10/18/2025

NCT06920719 Phase 1 COMPLETED

Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects

Started: 6/29/2025

NCT06926387 Phase 1 COMPLETED

Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy Subjects

Started: 4/17/2025

NCT03046992 Phase 1 COMPLETED

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

Started: 2/15/2017

NCT06775522 Phase 1 COMPLETED

Bioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers

Started: 1/11/2025

NCT05564221 Phase 1 COMPLETED

A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases

Started: 11/1/2022

NCT05162274 Phase 1 COMPLETED

Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.

Started: 11/30/2021

NCT05061524 Phase 1 COMPLETED

A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects with Mild Allergic Diseases

Started: 9/26/2021

NCT05960708 Phase 1 COMPLETED

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

Started: 8/23/2023

NCT06623526 Phase 1 COMPLETED

Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers

Started: 10/4/2024

NCT06613139 Phase 1 COMPLETED

Bioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers

Started: 10/6/2024

NCT03662620 Phase 1 COMPLETED

Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

Started: 10/5/2018

NCT06359626 Phase 1 COMPLETED

Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers

Started: 6/21/2024

NCT05012436 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

Started: 7/24/2021

NCT05418803 Phase 1 COMPLETED

BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects

Started: 1/28/2020

NCT02176668 Phase 1 COMPLETED

The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects

Started: 6/1/2014

NCT02817347 Phase 1 TERMINATED

A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea

Started: 6/1/2016

NCT04316065 Phase 1 COMPLETED

Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg

Started: 4/11/2020

NCT04225052 Phase 1 COMPLETED

Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers

Started: 12/19/2019

NCT03556436 Phase 1 COMPLETED

Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448

Started: 7/3/2018

NCT03116516 Phase 1 COMPLETED

Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin

Started: 4/21/2017

NCT03191136 Phase 1 COMPLETED

Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers

Started: 5/10/2017

NCT02783638 Phase 1 COMPLETED

PK and Food Effect of Pregabalin Study After Dosing in Healthy Male Volunteers

Started: 1/1/2016

NCT02783183 Phase 1 COMPLETED

A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin

Started: 6/1/2016

NCT03235362 Phase 1 COMPLETED

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706

Started: 8/7/2017

NCT02608242 Phase 1 TERMINATED

PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

Started: 11/1/2015

NCT02951962 Phase 1 COMPLETED

A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

Started: 8/1/2016

NCT02538367 Phase 1 COMPLETED

Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation

Started: 8/1/2015

NCT02496910 Phase 1 COMPLETED

PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton

Started: 6/1/2015

NCT01526330 Phase 1 COMPLETED

Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease

Started: 5/1/2012

NCT01870674 Phase 1 COMPLETED

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects

Started: 8/1/2013

NCT02233218 Phase 1 COMPLETED

The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

Started: 7/1/2014

NCT02152969 Phase 1 COMPLETED

Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)

Started: 5/1/2014

NCT02125227 Phase 1 COMPLETED

Phase 1 Clinical Trial to Investigate the Effect on the Pharmacokinetics of YH14755 Compared to Co-administration of Rosuvastatin and Metformin SR in Healthy Volunteers

Started: 4/1/2014

NCT01825707 Phase 1 COMPLETED

AME Study of [14C]-YH4808 in Healthy Male Subjects

Started: 1/1/2013

NCT01332890 Phase 1 COMPLETED

Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects

Started: 4/1/2011

NCT01007019 Phase 1 COMPLETED

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

Started: 11/1/2009

NCT01525147 Phase 1 COMPLETED

Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers

Started: 12/1/2011

NCT01761513 Phase 1 COMPLETED

YH4808 Postprandial PK/PD Study in Healthy Subjects

Started: 11/1/2012

NCT01876615 Phase 1 COMPLETED

Pharmacokinetic Drug Interaction Between YH4808 and Diclofenac

Started: 7/1/2013

NCT01921647 Phase 1 COMPLETED

The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

Started: 7/1/2013

NCT01992601 Phase 1 COMPLETED

A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer

Started: 11/1/2012

NCT01975961 Phase 1 COMPLETED

PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin

Started: 7/1/2013

NCT01657071 Phase 1 COMPLETED

Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects

Started: 3/1/2012

NCT01419470 Phase 1 COMPLETED

Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044

Started: 2/1/2011

NCT01526317 Phase 1 COMPLETED

A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers

Started: 12/1/2011

NCT01520012 Phase 1 COMPLETED

Food Effect on Pharmacokinetics of YH4808 in Healthy Male Subjects

Started: 2/1/2012

NCT01609907 Phase 1 COMPLETED

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

Started: 11/1/2011

NCT01422109 Phase 1 COMPLETED

Comparative Pharmacokinetics of YH14659

Started: 7/1/2011

NCT01420913 Phase 1 COMPLETED

Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects

Started: 8/1/2011

NCT06041529 Phase 4 ACTIVE NOT RECRUITING

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

Started: 10/18/2023

NCT04846673 Phase 4 COMPLETED

Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy

Started: 5/14/2021

NCT05730621 Phase 4 COMPLETED

A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

Started: 1/11/2023

NCT05624853 Phase 4 COMPLETED

A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain

Started: 5/12/2020

NCT06046196 Phase 4 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

Started: 11/18/2020

NCT03951207 Phase 4 COMPLETED

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

Started: 5/30/2019

NCT03232177 Phase 4 COMPLETED

Anagre Cap. in Patients With High-Risk Essential Thrombocythemia

Started: 6/5/2017

NCT03474562 Phase 4 COMPLETED

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

Started: 4/3/2018

NCT01869881 Phase 4 COMPLETED

Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)

Started: 2/1/2013

NCT03267329 Phase 4 COMPLETED

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Started: 9/11/2017

NCT03597412 Phase 4 COMPLETED

Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM

Started: 10/17/2018

NCT03509922 Phase 4 COMPLETED

A Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity

Started: 10/11/2018

NCT03494270 Phase 4 COMPLETED

High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients

Started: 3/18/2018

NCT03217409 Phase 4 COMPLETED

A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

Started: 8/10/2017

NCT04056169 Phase 4 COMPLETED

Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome

Started: 6/29/2017

NCT03446261 Phase 4 COMPLETED

Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia

Started: 2/23/2018

NCT02968160 Phase 4 TERMINATED

A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome

Started: 10/1/2016

NCT03334916 Phase 4 COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients

Started: 10/27/2017

Drug Candidates

Lesigercept Placebo YHP2511 YHP2511A YH32367 Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg YHP2401 YHR2402 YHR2403
Activity Status: Active
Last Trial Started: 6/23/2026
Last Trial Ended: 1/26/2026
Trials (12 months): 6
Completed Trials: 83
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.